The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Major unmet needs in the MCL patient population
In this video, Jonathon Cohen, MD, MS, Emory University School of Medicine, Atlanta, GA, briefly discusses unmet needs in mantle cell lymphoma (MCL), emphasizing the need to improve treatment options for patients who progress after CAR-T therapy and for patients who experience early disease progression after initial therapy. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
